We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer

This study has been terminated.
(The PI is no longer with Kentuckiana Cancer Institute. All current subjects completed. No further subjects will be enrolled. Terminated with IRB.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00283530
First Posted: January 30, 2006
Last Update Posted: January 20, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Kentuckiana Cancer Institute
  Purpose
The purpose of this study is to identify the genetic makeup of cancers, the cancer response, and the correlation of the cancer response to standardized regimens of cancer treatment.

Condition Intervention
Cancer Procedure: Tumor biopsy

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Identification of Tumor Phenotypes and Correlation to Clinical Outcomes in Patients Diagnosed With Cancer

Further study details as provided by Kentuckiana Cancer Institute:

Estimated Enrollment: 1000
Study Start Date: May 2003
Study Completion Date: July 2009
Detailed Description:
To identify the genetic makeup of cancers, the cancer response, and the correlation of the cancer response to standardized regimens of cancer treatment.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Cancer subjects who have or will have tissue and or blood collected.
Criteria

Inclusion Criteria:

  • Diagnosis of cancer receiving chemotherapy
  • Have had or will have tissue and/or blood samples collected
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00283530


Locations
United States, Kentucky
Kentuckiana Cancer Institute
Louisville, Kentucky, United States, 40202
Sponsors and Collaborators
Kentuckiana Cancer Institute
Investigators
Study Director: Shawn D. Glisson, MD Kentuckiana Cancer Institute
  More Information

ClinicalTrials.gov Identifier: NCT00283530     History of Changes
Other Study ID Numbers: 1050203
CPTAIV-0020-385
First Submitted: January 26, 2006
First Posted: January 30, 2006
Last Update Posted: January 20, 2010
Last Verified: January 2010

Keywords provided by Kentuckiana Cancer Institute:
Cancer
Cancer receiving chemotherapy
Tumor biopsy